Most of the thiol-containing enzymes, such as thioredoxin reductase (TrxR), glutathione reductase (GR), and cysteine protease, are overexpressed in cancer cells, thus providing potential anticancer targets for Au(I)-based therapy. This evidence concerns the gene GSR and cancer.